Abstract
Objective: The purpose of the study was to analyze the effect of clinical pharmacist intervention on glycemic control based on fasting blood glucose and glycosylated blood glucose level. Methods: A randomized prospective interventional study was conducted in the outpatient department of a tertiary care hospital. Patients suffering from diabetes for a least 2 y were selected for the study based on the inclusion and exclusion criteria. The control group was not given any special pharmacist care, while the interventional group had a face-to-face interview, counseling, and telephonic follow-up during the study period. Based on the baseline values and endpoint parametric values, the result of the study was analyzed. Results: The study was analyzed based on the difference in the glycemic index, using HbA1c and FBS values. The basal values of HbA1c were similar for both groups (8.5%), but a marked reduction to 7.2% was observed in the interventional group. FBS values reduced from 208 mg/dl to 186 mg/dl in the intervention group, while in the usual care group, the reduction was from 211 mg/dl to 198 mg/dl. Conclusion: The inclusion of clinical pharmacists in the healthcare team can offer a remarkable improvement in patient's condition by providing more support in the therapy.
Highlights
Diabetes Mellitus is one of the worldwide fastest emerging chronic metabolic disease which results in significantly raised morbidity, mortality and healthcare expenses
On compared with the usual care group, the interventional group patients achieved a greater reduction in the A1c values, which was clinically and statistically significant
It was found that in the intervention group the percentage of patients almost reached the American diabetes association goal (HbA1c ≤ 7%) was significantly higher compared to the usual care group
Summary
Diabetes Mellitus is one of the worldwide fastest emerging chronic metabolic disease which results in significantly raised morbidity, mortality and healthcare expenses. The cost of health care plans was calculated to be 2 to 3 times that of the patient of the same age without diabetes mellitus in the United States [3]. It was reported that there are different methods to prevent diabetes related morbidity [4]. One such method was by the utilization of the present management direction and positive changes in the monitoring of the pharmacotherapies, which included measuring blood sugar levels, and retinal screening. The management of the complicated multisystem and patient-oriented problems in a healthcare system requires severe follow-ups and critical personalized patient counseling and proper medical education [5]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
